Immune Tolerance Network
Karen Chia is a seasoned clinical operations professional with extensive experience in the healthcare sector. Currently serving as the Clinical Operations Manager at the Immune Tolerance Network since September 2012, Karen has previously held roles including Clinical Trials Manager and Clinical Site Coordinator (Consultant) at Mytrus Inc. from October 2010 to August 2012. Additional experience includes working as a Regulatory Consultant at Ivivi Health Sciences in 2011, Clinical Research Coordinator at UCSF from October 2009 to October 2010, and Research Study Coordinator at Mayo Clinic from November 2006 to October 2009. Karen Chia holds a Bachelor of Arts degree in Physiology from the University of Minnesota.
Immune Tolerance Network
The Immune Tolerance Network (ITN) is a collaborative network for clinical research, funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. Our mission is to accelerate the clinical development of immune tolerance therapies in asthma and allergy, autoimmune diseases, type 1 diabetes and solid organ transplantation. Immune tolerance therapies reprogram the immune system so that disease-causing immune responses are stopped while maintaining the immune system’s ability to combat pathogen infection. The ITN develops, funds and conducts clinical trials in conjunction with mechanistic, laboratory based studies.